---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018643"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:15:17.117478+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Technologies to present CyPath® Lung processing research at CHEST 2025

## Summary
- Poster presented Oct 22, 2025 by Rossella Titone, PhD at poster board #4324.
- Study evaluates sputum storage and shipping temperature effects on flow cytometry outcomes.
- Research supports protocols for home-collected sputum samples with two-day result turnaround.
- CyPath® Lung previously reported 92% sensitivity, 87% specificity, 88% accuracy in early-stage lung cancer detection.

## SEC filing metadata
- accession: 0001493152-25-018643
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/0001493152-25-018643-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018643
- JSON: https://secwatch.observer/filing/0001493152-25-018643.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018643.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.